Motley Fool Australia

Keith Speights

3 key advantages Moderna holds over Pfizer and AstraZeneca

They could add up to make Moderna a much bigger winner for investors than either of the two big pharma stocks. More »

Warren Buffett’s 3 best-performing stocks so far this year: Are they buys now?

These Buffett stocks have all delivered sizzling year-to-date gains. Can they keep the momentum going? More »

The surefire vaccine winner following AstraZeneca’s COVID-19 trial pause

Hint: It's not Moderna. More »

Coronavirus vaccine race: 7 key things you’ll want to know

Here are the answers to your top questions about where things stand with the development of COVID-19 vaccines. More »

How to invest in coronavirus vaccine stocks

Just follow these three simple steps. More »

This could be the ace in the hole for Johnson & Johnson’s COVID-19 vaccine

J&J is behind in the race to develop a COVID-19 vaccine. But there's one thing that could make it a come-from-behind winner. More »

Everything you need to know about the coronavirus vaccine race

Here are your answers to the questions that matter the most about COVID-19 vaccines in development More »

Johnson & Johnson to Begin Coronavirus Vaccine Clinical Trial in July

The healthcare giant's COVID-19 vaccine program is moving forward more quickly than expected. More »

Worried Another Stock Market Crash Is Coming? 3 Things You Should Do Right Now

You're not alone if you think another stock market crash is on the way. Here are three specific things you can and should do... More »

Warren Buffett’s Advice on How Investors Should Respond to a Super-Contagious Disease

The Oracle of Omaha has given some words of wisdom on exactly what you should do. More »

3 Warren Buffett stocks to buy in October

You don't have to be a billionaire to profit from these great stocks. More »